Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Bioanal Chem ; 406(16): 3853-61, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24390463

ABSTRACT

Nanosized titanium dioxide (TiO2) is one of the most interesting and valuable nanomaterials for the construction industry but also in health care applications, food, and consumer goods, e.g., cosmetics. Therefore, the properties associated with this material are described in detail. Despite its widespread use, the analytical determination and characterization of nanosized metal oxides is not as straightforward as the comparatively easy-to-detect metallic nanoparticles (e.g., silver or gold). This study presents the method development and the results of the determination of tissue titanium (Ti) levels after treatment of rats with the nanosized TiO2. Total Ti levels were chosen to evaluate the presence and distribution of TiO2 nanoparticles. A procedure consisting of incubation with a mixture of nitric acid (HNO3) and hydrofluoric acid (HF), and heating was developed to digest tissues and TiO2 nanomaterials in order to determine the total Ti content by inductively coupled plasma mass spectrometry (ICPMS). For the inter-laboratory comparison, altogether four laboratories analyzed the same samples upon digestion using the available ICPMS equipment. A major premise for any toxicokinetic study is the possibility to detect the chemical under investigation in biological samples (tissues). So, the study has to be performed with a dose high enough to allow for subsequent tissue level measurement of the chemical under investigation. On the other hand, dose of the chemical applied should not induce over toxicity in the animal as this may affect its absorption, distribution, metabolism, and excretion. To determine a non-toxic TiO2 dosage, an acute toxicity study in rats was performed, and the organs obtained were evaluated for the presence of Ti by ICPMS. Despite the differences in methodology and independent of the sample preparation and the ICPMS equipment used, the results obtained for samples with Ti concentrations >4 µg Ti/g tissue agreed well.


Subject(s)
Animal Structures/chemistry , Mass Spectrometry/methods , Nanoparticles/analysis , Titanium/analysis , Animals , Laboratories/standards , Male , Mass Spectrometry/standards , Rats , Rats, Wistar
2.
ACS Nano ; 5(4): 3059-68, 2011 Apr 26.
Article in English | MEDLINE | ID: mdl-21456612

ABSTRACT

Silver nanoparticles (SNP) are the subject of worldwide commercialization because of their antimicrobial effects. Yet only little data on their mode of action exist. Further, only few techniques allow for visualization and quantification of unlabeled nanoparticles inside cells. To study SNP of different sizes and coatings within human macrophages, we introduce a novel laser postionization secondary neutral mass spectrometry (Laser-SNMS) approach and prove this method superior to the widely applied confocal Raman and transmission electron microscopy. With time-of-flight secondary ion mass spectrometry (TOF-SIMS) we further demonstrate characteristic fingerprints in the lipid pattern of the cellular membrane indicative of oxidative stress and membrane fluidity changes. Increases of protein carbonyl and heme oxygenase-1 levels in treated cells confirm the presence of oxidative stress biochemically. Intriguingly, affected phagocytosis reveals as highly sensitive end point of SNP-mediated adversity in macrophages. The cellular responses monitored are hierarchically linked, but follow individual kinetics and are partially reversible.


Subject(s)
Macrophages/chemistry , Metal Nanoparticles , Nanotechnology , Silver/analysis , Spectrometry, Mass, Secondary Ion/methods , Toxicology , Humans , Macrophages/ultrastructure , Microscopy, Electron, Transmission , Oxidative Stress
3.
ALTEX ; 27(2): 117-34, 2010.
Article in English | MEDLINE | ID: mdl-21445538

ABSTRACT

In 2007, 2.7 million vertebrates were used for animal experiments and other scientific purposes in Germany alone. Since 1998 there has been an increase in the number of animals used for research purposes, which is partly attributable to the growing use of transgenic animals. These animals are, for instance, used as in vivo models to mimic human diseases like diabetes, cancer or Alzheimer's disease. Here, transgenic model organisms serve as valuable tools, being instrumental in facilitating the analysis of the molecular mechanisms underlying human diseases, and might contribute to the development of novel therapeutic approaches. Due to variable and, sometimes low, efficiency (depending on the species used), however, the generation of such animals often requires a large number of embryo donors and recipients. The experts evaluated methods that could possibly be utilised to reduce, refine or even replace experiments with transgenic vertebrates in the mid-term future. Among the promising alternative model organisms available at the moment are the fruit fly Drosophila melanogaster and the roundworm Caenorhabditis elegans. Specific cell culture experiments or three-dimensional (3D) tissue models also offer valuable opportunities to replace experiments with transgenic animals or reduce the number of laboratory animals required by assisting in decision-making processes. Furthermore, at the workshop an in vitro technique was presented which permits the production of complete human antibodies without using genetically modified ("humanised") animals. Up to now, genetically modified mice are widely used for this purpose. Improved breeding protocols, enhanced efficiency of mutagenesis as well as training of laboratory personnel and animal keepers can also help to reduce the numbers of laboratory animals. Well-trained staff in particular can help to minimise the pain, suffering and discomfort of animals and, at the same time, improve the quality of data obtained from animal experiments. This, in turn, can lead to a reduction in the numbers of animals needed for each experiment. The experts also came to the conclusion that the numbers of laboratory animals can be reduced by open access to a central database that provides detailed documentation of completed experiments involving transgenic animals. This documentation should not be restricted to experiments with substantial scientific results that warrant publication, but should also include those with "negative" outcome, which are usually not published. Capturing all kinds of results within such a database provides added value to the respective scientists and the scientific community as a whole; it could also help to stimulate collaborations and to ensure funding for future research. An important aspect to be considered in the generation of this kind of database is the quality and standardisation of the information provided on existing in vitro models and the respective opportunities for their use. The experts felt that the greatest potential for reducing the numbers of laboratory animals in the near future realistically might not be offered by the complete replacement of transgenic animal models but by opportunities to examine specific questions to a greater degree using in vitro models, such as cell and tissue cultures including organotypic models. The use of these models would considerably reduce the number of in vivo experiments using transgenic animals. However, the overall number of experimental animals may still be increasing or remain unaffected, e.g. when transgenic animals continue to serve as the source of primary cells and organs/tissues for in vitro experiments.


Subject(s)
Animal Testing Alternatives/ethics , Animal Testing Alternatives/methods , Animals, Genetically Modified , Research/standards , Animal Welfare , Animals , Bioethics , Mice , Research Design , Time Factors , Tissue Array Analysis
4.
Cancer Lett ; 266(1): 73-83, 2008 Jul 18.
Article in English | MEDLINE | ID: mdl-18367325

ABSTRACT

Reactive oxygen and nitrogen species (ROS and RNS) are known to contribute as pathogenic factors to the development of chronic progressive diseases at various stages. The present review discusses the role of oxidative stress in chemically induced cancer development and progression. Reactive species are capable of inducing DNA damage that eventually may contribute to cell transformation and tumor initiation. ROS and RNS are also associated with tumor promotion and progression. Both endogenous processes and redox-cycling of xenobiotic compounds have been shown to result in oxidative DNA damage. In addition, several exocyclic DNA adducts represent secondary DNA damage caused by products of lipid peroxidation in the course of oxidative cellular stress. Due to their intrinsic ability to catalyze redox reactions, transition metals, and quinones from various classes of xenobiotics or endogenous compounds are important mediators of oxidative stress and thus likely of being involved in DNA damage, lipid peroxidation, cell transformation, and tumor development.


Subject(s)
Carcinogens , DNA Damage , Neoplasms/chemically induced , Neoplasms/metabolism , Oxidative Stress , Reactive Nitrogen Species , Reactive Oxygen Species , Animals , Cell Transformation, Neoplastic , Humans , Lipid Peroxidation , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...